Long-term use of depot medroxy progesterone acetate as a contraceptive
el-Mahgoub, S.; Karim, M.; Ammar, R.
Acta Obstetricia et Gynecologica Scandinavica 51(3): 251-255
1972
ISSN/ISBN: 0001-6349 PMID: 5072160 Document Number: 55053
Document emailed within 1 workday
Related Documents
Taneepanichskul, S.; Patrachai, S. 1998: Effects of long-term treatment with depot medroxy progesterone acetate for contraception on estrogenic activity Journal of the Medical Association of Thailand 81(12): 944-946Who 1982: Multinational comparative clinical trial of long acting injectable contraceptives norethisterone enanthate given in 2 dosage regimens and depot medroxy progesterone acetate Contraception 25(1): 1-12
Who 1982: Multinational comparative clinical trial of long acting injectable contraceptives norethisterone enanthate given in 2 dosage regimens and depot medroxy progesterone acetate Contraception 25(1): 1-12
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Saxena, B.N.; Dusitsin, N.; Tankeyoon, M.; Chaudhury, R.R. 1980: Return of ovulation after the cessation of depot-medroxy progesterone acetate treatment in Thai women Journal of the Medical Association of Thailand 63(2): 66-69
Modesto, W.; Bahamondes, M.V.; Bahamondes, L. 2015: Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate Journal of Women's Health 24(8): 636-640
Wakatsuki, A.; Okatani, Y.; Fukaya, T. 2003: Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance Circulation 107(20): E197; Author Reply E197
Yamada, T.; Yuyama, Y.; Okazaki, Y. 2004: A long-surviving patient with Stage IV breast cancer with no recurrence after combined therapy of medroxy progesterone acetate (MPA) and intra-arterial infusion chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1387-1389
Rao, M.V.; Roy, G.K.; Prasannalata, S.N. 1998: Effect of medroxy progesterone acetate and testosterone enanthate on vas deferens of rats Indian Journal of Experimental Biology 36(2): 157-161
Bandopadhyaya, G.P.; Das, R.P.; Roy, S. 1976: Effect of a low dose of medroxy progesterone acetate on the reproductive organs and fertility of male rats Indian Journal of Medical Research 64(4): 518-522
Bandopadhyaya, G.P.; Das, R.P.; Roy, S. 1976: Effect of a low dose of medroxy progesterone acetate on the reproductive organs and fertility of male rats Indian Journal of Medical Research 64(4): 518-522
Cundy, T.; Cornish, J.; Roberts, H.; Reid, I.R. 2002: Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception American Journal of Obstetrics and Gynecology 186(5): 978-983
Cheewadhanaraks, S. 2013: Cumulative recurrence rates of endometriosis-associated pain after long-term intramuscular depot medroxyprogesterone acetate therapy Journal of the Medical Association of Thailand 96(2): 140-143
Wong, A.Y.K.; Tang, L.C.H.; Chin, R.K.H. 2010: Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial Australian and New Zealand Journal of Obstetrics and Gynaecology 50(3): 273-279
Sereepapong, W.; Chotnopparatpattara, P.; Taneepanichskul, S.; Markham, R.; Russell, P.; Fraser, I.S. 2004: Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users Human Reproduction 19(3): 547-552
Govender, Y.; Avenant, C.; Verhoog, N.J.D.; Ray, R.M.; Grantham, N.J.; Africander, D.; Hapgood, J.P. 2014: The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor Plos one 9(5): E96497
Chotnopparatpattara, P.; Taneepanichskul, S.; Treratanachat, S.; Charuruks, N. 2003: Relationship between progesterone receptor level in endometrium and bleeding pattern in depot medroxyprogesterone acetate users Journal of the Medical Association of Thailand 86(2): 172-177
Mettler, L.; Shirwani, D.; Brunnberg, F.J. 1979: Thombocyte function in relation to the long term application of medroxyprogesterone acetate as a female contraceptive agent Journal of Postgraduate Medicine 25(3): 154-157